Plastic Surgery Practice magazine is proud to welcome its newest editorial advisory board member, Jason Emer, MD, a fellowship-trained, board-certified dermatologist at Spalding Drive Plastic Surgery in Beverly Hills, Calif. Emer earned his MD at the University of Illinois at College of Medicine in Chicago and went on to complete his preliminary medicine internship at […]
The FDA has green lighted a phase III clinical study of ALPHAEON’S EVOSYAL™ for the treatment of glabellar lines.
Angelina Jolie’s lips and cheekbones, Beyonce’s facial structure, Kim Kardashian’s eyes and jawline, Brad Pitt’s nose and Natalie Portman’s nose topped the list of celebrity features requested by patients in 2014.
In February’s Edge, David Evans, PhD, MBA, helps readers decipher the true meaning behind Google’s “Zoo” updates.
The UK’s Royal College of Surgeons is trying to rein in cosmetic cowboys. What do you think about the proposal?
A mutated version of the AHNAK gene may help researchers better understand how keloid scars form and could potentially lead to better treatments for these scars.
In the Feb. 2015 Shorr Thing, Jay Shorr discusses why social media background checks on prospective employees are essential.
In the first PSP Master Class, Ivo Pitanguy, MD, a founding father of plastic surgery, talks about his lifelong quest for learning and what really matters to him.
PSP editor Denise Mann discusses all the exciting changes in store for the brand in 2015.
Novartis’ Cosentyx is the first approved human monoclonal antibody that selectively binds to interleukin IL-17A.